Alx Oncology Holdings Other 8-K Filing
ALX Oncology entered into exchange agreements with certain stockholders, including funds affiliated with Blackstone, RA Capital, and venBio, to exchange 13,353,384 shares of common stock for an equivalent number of pre-funded warrants. This transaction is a non-cash exchange of equity classes intended to manage beneficial ownership levels, as the warrants include exercise limitations to prevent holders from exceeding specific ownership thresholds.
- Counterparty
- Blackstone Annex Master Fund L.P.